Bellicum Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.64
|
-0.23
|
0.41
|
64.06%
|
|
2022-06-30
|
-0.69
|
-0.13
|
0.56
|
81.16%
|
|
2022-03-31
|
-0.67
|
-0.25
|
0.42
|
62.69%
|
|
2021-12-31
|
-0.40
|
0.11
|
0.51
|
127.50%
|
|
2021-09-30
|
-0.85
|
0.07
|
0.92
|
108.24%
|
|
2021-06-30
|
-1.37
|
-0.22
|
1.15
|
83.94%
|
|
2021-03-31
|
-1.37
|
-1.08
|
0.29
|
21.17%
|
|
2020-12-31
|
-1.06
|
0.98
|
2.04
|
192.45%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.61
|
|
2021-12-31
|
-1.12
|
|
2020-12-31
|
-6.66
|
|
2019-12-31
|
-23.92
|
|
2018-12-31
|
-24.60
|
|
2017-12-31
|
-8.35
|
|
2016-12-31
|
-2.57
|
|
2015-12-31
|
-1.84
|
|
2014-12-31
|
-2.02
|